G
67.87
-0.37 (-0.54%)
| Penutupan Terdahulu | 68.24 |
| Buka | 67.98 |
| Jumlah Dagangan | 433,177 |
| Purata Dagangan (3B) | 704,648 |
| Modal Pasaran | 3,031,497,216 |
| Harga / Jualan (P/S) | 16.50 |
| Harga / Buku (P/B) | 1.19 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -482.59% |
| EPS Cair (TTM) | -59.59 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 19.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.67% |
| Nisbah Semasa (MRQ) | 9.70 |
| Aliran Tunai Operasi (OCF TTM) | -464.88 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -236.88 M |
| Pulangan Atas Aset (ROA TTM) | -11.98% |
| Pulangan Atas Ekuiti (ROE TTM) | -62.22% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | GRAIL, Inc. | Bercampur | Menaik |
AISkor Stockmoo
0.5
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.50 |
|
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 14.18% |
| % Dimiliki oleh Institusi | 66.50% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |